European Companies Search Engine
Wordmark: “YELLOWSTONE BIOSCIENCES“ Euipotm5 Sept 2025 European Union Intellectual Property Office (Trade Marks)
History
Text
Trade mark
| Type | Word |
| Name | YELLOWSTONE BIOSCIENCES |
| Filing number | 019163967 |
| Trade mark status | REGISTERED |
| Nice Classification |
5: Pharmaceutical preparations and substances; immunotherapy preparations; pharmaceutical and biological preparations and substances for immunotherapy; therapeutic vaccines; genetic medicines; soluble T-cell receptor (TCT) based therapies; diagnostic reagents for medical purposes; synthetic peptides, proteins and cells for pharmaceutical purposes; peptides, proteins and cells for medical, diagnostic or therapeutic purposes; in vitro diagnostic reagents, in vivo diagnostic reagents, immunological reagents for medical use; biological reagents for medical/clinical diagnosis; diagnostic kits comprising reagents and medical diagnostic tests; biological reagents for medical research; biological reagents for medical use; biological preparations for medical use; immuno-therapeutic agents; antigen binding molecules, antibodies, antibody fragments, bi-specific T cell engagers (BiTEs), T cell receptors (TCRs) and chimeric antigen receptors (CARs); pharmaceutical preparations and substances for the treatment of cancer; biotechnological preparations for the treatment of cancer; immunotherapy preparations for the treatment of cancer; genetic medicines for the treatment of cancer; soluble T-cell receptor (TCR) based therapies for the treatment of cancer; immunotherapy products in oncology; preparation of therapeutic vaccines in oncology for human use; preparation of immunotherapy products in oncology for human use; T-cell receptors; immunotherapy preparations comprising engineered T-cell receptors; immunotherapy preparations comprising genes encoding engineered T-cell receptors; all of the aforesaid goods only for use in connection with immunotherapy. 42: Scientific, medical and pharmaceutical research and development services in the field of immunotherapy; pharmaceutical drug development services; research and development of pharmaceutical preparations; research and analysis services; biological research; clinical research; scientific research in the field of chemistry, biochemistry and biology; services of a biological, biochemical or chemical laboratory; performing of biological, biochemical or chemical analysis; cancer diagnostics for scientific purposes; biological and biochemical examination services; tests in laboratories; development of testing methods; research, development, technical design, testing, design and development of software in the field of biology; consultancy and analysis services in the field of immuno-therapeutics and in particular immune-oncology; Pharmaceutical product research and development; Biotechnology research and development; vaccine and immunotherapy research and development; research and development services in relation to pharmaceutical preparations and substances; research and development services in relation to pharmaceutical and biological preparations and substances for immunotherapy; research and development services in relation to gene therapy, cell therapy and genetic medicines; pharmaceutical and biological research and development services in connection with the treatment of cancer; research and development services in connection with gene therapy, cell therapy, genetic medicines and soluble T-cell receptor (TCR) based therapies for the treatment of cancer; advice, information and consultancy in connection with all of the aforesaid services; all of the aforesaid services only for use in connection with immunotherapy. 44: Provision of medical information; Provision of medical information via a website; medical counselling and medical information relating to pharmaceuticals, immunotherapy, immune-therapeutic treatments, therapeutic vaccines and genetic medicines; services of a medical laboratory, providing medical supply for therapy, in particular supply of peptides, proteins or cells for immuno-therapy; medical diagnostics; medical monitoring, testing, inspection and analysis services relating to the diagnosis and treatment by immune-therapeutics; medical and pharmaceutical consultancy; provision of medical information and services in the field of immuno-therapeutics; provision of medical treatment services and medical information services in relation to immuno-therapeutics. |
| Filing date | 27/03/2025 |
| Registration date | 04/09/2025 |
| Expiry date | 27/03/2035 |
| Owners |
Yellowstone Biosciences Limited 3rd Floor, 1 Ashley Road Altrincham Cheshire WA14 2DT United Kingdom |
The filing refers to a past date, and does not necessarily reflect the current state. The current state is available on the following page: Yellowstone Biosciences Ltd., Oxford.